Optovue
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | Series A | ||
$10.5m | Series B | ||
N/A | $30.0m | Growth Equity VC | |
Total Funding | CAD55.2m |
Recent News about Optovue
EditOptovue is a leading provider of Optical Coherence Tomography (OCT) and Optical Coherence Tomography Angiography (OCTA) systems, specializing in advanced imaging solutions for eye care professionals. Serving ophthalmologists and optometrists, Optovue operates in the global ophthalmic diagnostic imaging market. The company's business model revolves around the development, manufacturing, and sale of high-precision imaging devices that help clinicians diagnose and treat ocular diseases more effectively. Revenue is generated through the sale of these imaging systems, as well as through ongoing customer support and training services. Optovue's technology enables detailed visualization of the eye's structures, from the anterior segment to the choroid, and the retinal vasculature, enhancing clinical decision-making and patient care.
Keywords: OCT, OCTA, ophthalmic imaging, eye care, ocular disease, diagnostic tools, retinal vasculature, anterior segment, choroid, clinical decision-making.